ENTITY

Fujian Haixi Pharmaceuticals (FHP HK)

6
Analysis
Health Care • Hong Kong

•24 Mar 2026 08:28

HK: Cornerstone/Pre-IPO Lock-Up Expiries in April

There are 6 companies that listed in Oct where the lock-up for cornerstone investors ends in April. JST has a pre-IPO expiry too. The total lock-up...

Logo
888 Views
Share
bullish•HashKey
•05 Jan 2026 05:50

HSCI Index Rebalance Preview and Stock Connect (Mar 2026): Many Changes Following Huge IPO Quarter

There could be 74 changes for the HSCI in March. That could result in 64 changes to the Southbound Stock Connect list and also have implications...

Logo
1.5k Views
Share
•29 Nov 2025 11:05

Hong Kong: IPO SPOTLIGHT - OVERVIEW 2025

Hong Kong is the top global destination for IPOs in 2025, with over HK $280 billion raised so far.  Large scale A+H dual listings have surged this...

Logo
961 Views
Share
•13 Oct 2025 08:30

Fujian Haixi Pharmaceuticals IPO: Expanding Portfolio Augurs Well for Sustainable Growth

Haixi Pharmaceuticals is offering 11.5M H shares at HK$86.40 per share for its HK IPO to raise up to HK$994M. IPO proceeds will fund R&D of...

Logo
669 Views
Share
•27 Feb 2025 08:55

Pre-IPO Fujian Haixi Pharmaceuticals - The Concerns on the Pipeline and the Outlook

Generic drugs ​sales are key for Haixi's performance, but future growth will be hindered by VBP. Considering R&D failure risk of C019199, no...

Logo
774 Views
Share
x